The JSH Morning Hypertension Eradication Program Project.

IF 4.6 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE
Kazuomi Kario, Akira Nishiyama, Shigeru Shibata, Masaki Mogi, Hisatomi Arima, Takuya Kishi, Mari Ishida, Masato Furuhashi, Atsuhiro Ichihara, Tomohiro Katsuya, Katsuyuki Miura, Shin-Ichiro Miura, Mitsuru Ohishi, Hirotaka Shibata, Tatsuo Shimosawa, Akira Sugawara, Kouichi Tamura, Kazunori Toyoda, Koichi Yamamoto, Satoshi Hoshide, Naoki Nakagawa, Hirofumi Tomita, Atsushi Tanaka, Atsushi Hozawa, Tsuguru Hatta, Akihiro Nomura, Mai Kabayama, Hiromi Rakugi, Yusuke Ohya, Koichi Node
{"title":"The JSH Morning Hypertension Eradication Program Project.","authors":"Kazuomi Kario, Akira Nishiyama, Shigeru Shibata, Masaki Mogi, Hisatomi Arima, Takuya Kishi, Mari Ishida, Masato Furuhashi, Atsuhiro Ichihara, Tomohiro Katsuya, Katsuyuki Miura, Shin-Ichiro Miura, Mitsuru Ohishi, Hirotaka Shibata, Tatsuo Shimosawa, Akira Sugawara, Kouichi Tamura, Kazunori Toyoda, Koichi Yamamoto, Satoshi Hoshide, Naoki Nakagawa, Hirofumi Tomita, Atsushi Tanaka, Atsushi Hozawa, Tsuguru Hatta, Akihiro Nomura, Mai Kabayama, Hiromi Rakugi, Yusuke Ohya, Koichi Node","doi":"10.1038/s41440-025-02330-9","DOIUrl":null,"url":null,"abstract":"<p><p>Hypertension is the greatest risk factor for cardiovascular diseases and significantly contributes to cardiovascular mortality. In Japan, the hypertensive population is estimated at 43 million, with only 27% achieving well-controlled blood pressure (BP). The onset of major cardiovascular events, including stroke, myocardial infarction, heart failure, and aortic dissection, frequently occurs during the early morning hours. Accordingly, for over 20 years, the Japanese Society of Hypertension (JSH) has prioritized the management of early morning hypertension and has emphasized the importance of antihypertensive treatment guided by home BP in its treatment guidelines. However, even among hypertensive patients with multiple medications, control of morning BP remains suboptimal, with fewer than 30% achieving target levels below 130/80 mmHg. To address this serious situation, JSH announced their Declaration for the Eradication of Morning Hypertension in 2025, in conjunction with the release of the Guidelines for the Management of Elevated Blood Pressure and Hypertension 2025. The primary specific measure of the declaration involves the Asakatsu BP Action Plan - the Morning Blood Pressure 130 Campaign - which encourages individuals to monitor their morning blood pressure (BP) in various settings, such as homes, workplaces, and BP kiosks set up in public spaces. Additionally, JSH is promoting a Systematic Review Project to raise awareness of the importance of early morning hypertension management nationally and internationally, and a Data Science Project to examine how digital technology can contribute to the promotion of personalized and anticipation medicine through \"digital hypertension\" research.</p>","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":" ","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hypertension Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41440-025-02330-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Hypertension is the greatest risk factor for cardiovascular diseases and significantly contributes to cardiovascular mortality. In Japan, the hypertensive population is estimated at 43 million, with only 27% achieving well-controlled blood pressure (BP). The onset of major cardiovascular events, including stroke, myocardial infarction, heart failure, and aortic dissection, frequently occurs during the early morning hours. Accordingly, for over 20 years, the Japanese Society of Hypertension (JSH) has prioritized the management of early morning hypertension and has emphasized the importance of antihypertensive treatment guided by home BP in its treatment guidelines. However, even among hypertensive patients with multiple medications, control of morning BP remains suboptimal, with fewer than 30% achieving target levels below 130/80 mmHg. To address this serious situation, JSH announced their Declaration for the Eradication of Morning Hypertension in 2025, in conjunction with the release of the Guidelines for the Management of Elevated Blood Pressure and Hypertension 2025. The primary specific measure of the declaration involves the Asakatsu BP Action Plan - the Morning Blood Pressure 130 Campaign - which encourages individuals to monitor their morning blood pressure (BP) in various settings, such as homes, workplaces, and BP kiosks set up in public spaces. Additionally, JSH is promoting a Systematic Review Project to raise awareness of the importance of early morning hypertension management nationally and internationally, and a Data Science Project to examine how digital technology can contribute to the promotion of personalized and anticipation medicine through "digital hypertension" research.

JSH早晨高血压根除计划项目。
高血压是心血管疾病的最大危险因素,是导致心血管疾病死亡的重要因素。在日本,高血压人群估计有4300万,其中只有27%的人血压得到了良好控制。主要心血管事件,包括中风、心肌梗死、心力衰竭和主动脉夹层,经常发生在清晨。因此,20多年来,日本高血压学会(JSH)在其治疗指南中优先考虑清晨高血压的管理,并强调以家庭血压为指导的降压治疗的重要性。然而,即使在服用多种药物的高血压患者中,早晨血压的控制仍然不理想,只有不到30%的人达到130/80 mmHg以下的目标水平。为了解决这一严重问题,JSH宣布了《2025年消除晨间高血压宣言》,同时发布了《2025年高血压和高血压管理指南》。该宣言的主要具体措施涉及Asakatsu血压行动计划-早晨血压130运动-鼓励个人在各种环境中监测他们的早晨血压(BP),例如家庭,工作场所和设置在公共场所的BP亭。此外,JSH正在推进一个系统评估项目,以提高人们对国内和国际上清晨高血压管理重要性的认识,以及一个数据科学项目,以研究数字技术如何通过“数字高血压”研究促进个性化和预诊医学。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hypertension Research
Hypertension Research 医学-外周血管病
CiteScore
7.40
自引率
16.70%
发文量
249
审稿时长
3-8 weeks
期刊介绍: Hypertension Research is the official publication of the Japanese Society of Hypertension. The journal publishes papers reporting original clinical and experimental research that contribute to the advancement of knowledge in the field of hypertension and related cardiovascular diseases. The journal publishes Review Articles, Articles, Correspondence and Comments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信